Taoka Chemical Company, Limited revised earnings guidance for the full year ending March 31, 2023. For the year, the company expected sales revenue of JPY 31,000 million, Operating income of JPY 500 million, Net income attributable to owners of the parent of JPY 300 million or JPY 20.94 per share compared to the previous guidance of Sales revenue of JPY 33,000 million, Operating income of JPY 1,250 million, Net income attributable to owners of the parent of JPY 800 million or JPY 55.83 per share provided earlier.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
777 JPY | -0.13% | -0.38% | +7.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.77% | 72.81M | |
+1.22% | 78.18B | |
+0.59% | 47.18B | |
+0.96% | 32.47B | |
+8.75% | 18.01B | |
-9.28% | 11.74B | |
+8.55% | 11.47B | |
-2.33% | 10.43B | |
+5.97% | 9.98B | |
+3.48% | 9.12B |
- Stock Market
- Equities
- 4113 Stock
- News Taoka Chemical Company, Limited
- Taoka Chemical Company, Limited Revises Earnings Guidance for the Full Year Ending March 31, 2023